Skip to content

Clinical trials

Leukemia, Myeloid, Acute trials with unknown status

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Leukemia, Myeloid, Acute Status: Unknown status Clear all

372 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20002
20013
20022
20032
20048
20056
20064
20076
20087
20095
201022
201111
201212
201310
201414
201510
201623
201727
201825
201927
202032
202139
202238
202318
20246

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status372

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
The First Affiliated Hospital of Soochow University20
Nanfang Hospital, Southern Medical University9
Assiut University7
European Organisation for Research and Treatment of Cancer - EORTC7
PersonGen BioTherapeutics (Suzhou) Co., Ltd.7
National Taiwan University Hospital6
Assistance Publique - Hôpitaux de Paris5
Institut Paoli-Calmettes5
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.4
Chinese PLA General Hospital4

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Leukemia, Myeloid, Acute372
Myelodysplastic Syndromes66
Leukemia54
Precursor Cell Lymphoblastic Leukemia-Lymphoma45
Recurrence31
Lymphoma, Non-Hodgkin21
Lymphoma18
Multiple Myeloma17
Congenital Abnormalities16
Hodgkin Disease15

Trials

Showing 1 to 25 of 372. Each trial links to its page on Pharma Observatory.

272 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.